Quantum-Si

Come join our team as a Staff Mechanical Engineer! Are you a highly motivated and experienced #mechanicalengineer with a passion for innovation? Quantum-Si is looking for a talented Staff Mechanical Engineer to join our Instrument Engineering team and play a crucial role in the development of our Next-Generation Protein Sequencer™. Apply now and be part of our journey to transform scientific discovery! #JobOpportunity #Innovation #Proteomics #QSI

We are incredibly proud of Meredith L. Carpenter, PhD, Head of Scientific Affairs at Quantum-Si, who is leading the way for women in science. Check out her Q&A as she shares her journey as a female leader in science in what has historically been a male-dominated industry. How lucky are we that she has joined us to put the groundbreaking power of protein sequencing in the hands of every scientist. Discover her insights at the link below. #WomenInScience #ProteinSequencing #Inclusion #Mentorship #QSI

Calling all protein scientists: augment your proteomics repertoire with Platinum®, the world's first Next-Generation Protein Sequencer™. Uncover more insights without the expensive equipment or advanced expertise. Download the app note to see how the Platinum workflow can expand your research: https://lnkd.in/gRhE3yJg

Dive into our new application landing page to grasp how Platinum®, the Next-Generation Protein Sequencer™, optimizes protein variant detection with unparalleled precision. Check it out here: https://lnkd.in/dG3iY7_T

This week, we sequenced DLL1, short for Delta-Like Protein 1. DLL1 is an essential ligand for the Notch signaling pathway and is pivotal in embryonic development, maintaining adult stem cell populations, and ensuring proper tissue homeostasis. Therapeutically, DLL1 modulation offers promising avenues in oncology, as aberrant Notch signaling is implicated in many cancers, including T-cell acute lymphoblastic leukemia and breast cancer. Additionally, DLL1's influence on stem cell differentiation makes it a potential target in regenerative medicine, aiming to repair or replace damaged tissues. Our sequencing result demonstrates how Next-Generation Protein Sequencing™ data on the Platinum® instrument can be used to sequence and characterize potential therapeutic targets, such as DLL1. By analyzing the kinetic signatures from specific N-terminal amino acid recognizers, we identified 13 amino acids (F, Y, W, L, I, V, R, A, S, N, Q, E, and K), enabling identification of 4 peptides of DLL1 as shown in the figure. Discover the power of Platinum® and download our application notes here: https://lnkd.in/dsUSBvsh Which protein should be sequenced next? Let us know by commenting on this post or contact us here: https://lnkd.in/e6hVNEdm #proteomics #QSI #proteinsequencing #NGPS #biotech

Introducing Brian Reed's Latest Blog: The Next Big Thing in Genomics Next-generation DNA sequencing has transformed our understanding of biology, but there's a crucial gap in validating data at the functional level. Proteomics closes this gap as proteins play a vital role in understanding biological dynamics. With Next-Generation Protein Sequencing™ on Quantum-Si’s Platinum®, researchers can uncover intricate protein details, advancing biological research and therapeutic development. Check out Dr. Reed’s blog here to learn how NGPS can add a new dimension to your research: https://lnkd.in/giDQM6bM #Proteomics #NGPS #BiologicalResearch

Our article in Science "Real-time dynamic single-molecule protein sequencing on an integrated semiconductor device" details the science behind the #Platinum® Next-Generation Protein Sequencer™. Learn about the latest advancements in the journey to mapping the human proteome! Read the publication here: https://bit.ly/46kjYwk #NGPS #Proteomics #QSI

Quantum-Si will report Q2 financial results on Wednesday, August 7, 2024. That same day at 4:30m ET, #QSI will host a conference call to discuss financial results & provide a business update. Register for the call: https://bit.ly/46dJV0z

Identify low-abundant proteins from complex biological matrices. Discover our immunoprecipitation protocol compatible with Quantum-Si’s Platinum®, the Next-Generation Protein Sequencer™, for identifying #proteins with single amino acid resolution. Read the App Note here: https://bit.ly/3Y8m8gg #NGPS #proteomics #QSI

This week, we sequenced B2MG, short for Beta-2-Microglobulin. B2MG is a component of the major histocompatibility complex (MHC) class I molecules, which are involved in the presentation of peptide antigens to the immune system. It plays a critical role in immune surveillance by helping to display intracellular proteins on the cell surface for recognition by cytotoxic T cells. Elevated levels of B2MG are associated with chronic kidney disease and certain malignancies, making it a potential biomarker for these conditions and a target for therapeutic intervention. Our sequencing result demonstrates how Next-Generation Protein Sequencing™ data on the Platinum® instrument can be used to sequence and characterize potential therapeutic targets, such as B2MG. By analyzing the kinetic signatures from specific N-terminal amino acid recognizers, we identified 13 amino acids (F, Y, W, L, I, V, R, A, S, N, Q, E, and K), enabling identification of 3 peptides of B2MG as shown in the figure. Discover the power of Platinum® and download our application notes here: Which protein should be sequenced next? Let us know by commenting on this post or contact us here: https://lnkd.in/e6hVNEdm #proteomics #QSI #proteinsequencing #NGPS #biotech